Epidemiology of heart failure with preserved ejection fraction A Dhingra, A Garg, S Kaur, S Chopra, JS Batra, A Pandey, AH Chaanine, ... Current heart failure reports 11, 354-365, 2014 | 150 | 2014 |
Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic … ST Tagawa, S Vallabhajosula, PJ Christos, YS Jhanwar, JS Batra, L Lam, ... Cancer 125 (15), 2561-2569, 2019 | 125 | 2019 |
Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular Compartment DP Nguyen, PL Xiong, H Liu, S Pan, W Leconet, V Navarro, M Guo, J Moy, ... Molecular Cancer Research 14 (11), 1045-1053, 2016 | 45 | 2016 |
Phase I trial of docetaxel plus lutetium-177-labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate … JS Batra, MJ Niaz, YE Whang, A Sheikh, C Thomas, P Christos, ... Urologic Oncology: Seminars and Original Investigations 38 (11), 848. e9-848 …, 2020 | 41 | 2020 |
Anti-PSMA/CD3 bispecific antibody delivery and antitumor activity using a polymeric depot formulation W Leconet, H Liu, M Guo, S Le Lamer-Déchamps, C Molinier, S Kim, ... Molecular Cancer Therapeutics 17 (9), 1927-1940, 2018 | 40 | 2018 |
Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 (177Lu‐J591) for Metastatic … MJ Niaz, JS Batra, RD Walsh, MK Ramirez‐Fort, S Vallabhajosula, ... The oncologist 25 (6), 477-e895, 2020 | 35 | 2020 |
Transfusion-transmitted virus in association with hepatitis AE viral infections in various forms of liver diseases in India M Irshad, Y Sharma, I Dhar, J Singh, YK Joshi World Journal of Gastroenterology: WJG 12 (15), 2432, 2006 | 29 | 2006 |
Formalizing an integrative, multidisciplinary cancer therapy discovery workflow MF McGuire, H Enderling, DI Wallace, J Batra, M Jordan, S Kumar, ... Cancer research 73 (20), 6111-6117, 2013 | 23 | 2013 |
A quest to identify prostate cancer circulating biomarkers with a bench‐to‐bedside potential JS Batra, S Girdhani, L Hlatky Journal of biomarkers 2014 (1), 321680, 2014 | 18 | 2014 |
Uncommon cancers of the prostate ST Tagawa, NH Akhtar, BD Robinson, H Beltran Textbook of uncommon cancer, 47-75, 2012 | 14 | 2012 |
Final results of 2-dose fractionation of 177Lu-J591 for progressive metastatic castration-resistant prostate cancer (mCRPC). ST Tagawa, J Batra, S Vallabhajosula, Y Jhanwar, PJ Christos, ... J Clin Oncol 34, (suppl; abstr 5022), 2016 | 12 | 2016 |
Can the interplay between androgen signaling and PSMA expression be leveraged for theranostic applications? JS Batra, KJ Pienta, MG Pomper, MA Gorin, SP Rowe Translational Andrology and Urology, 2019 | 10 | 2019 |
Fractionated dose radiolabeled antiprostate specific membrane antigen (PSMA) radioimmunotherapy (177Lu-J591) with or without docetaxel for metastatic … JS Batra, BS Karir, S Vallabhajosula, PJ Christos, G Hodes, PR Date, ... Journal of Clinical Oncology 33 (7_suppl), 194-194, 2015 | 6 | 2015 |
DOSE-FRACTIONATED ANTI-PSMA RADIOIMMUNOTHERAPY (177LU-J591) FOR MCRPC: MP50-19 JS Batra, B Karir, K Pinto-Chengot, YS Jhanwar, S Vallabhajosula, ... Journal of Urology 195 (4), e680, 2016 | 5 | 2016 |
Injection safety awareness and knowledge among slum population P Misra, A Goswami, CS Pandav Indian Journal of Community Medicine 28 (3), 125-127, 2003 | 4 | 2003 |
PSMA-targeted alpha radioimmunotherapy for prostate cancer with 225Ac-J591 JS Batra, H Liu, S Kim, VN Navarro, S Vallabhajosula, ST Tagawa, ... Cancer Research 77 (13_Supplement), 5201-5201, 2017 | 3 | 2017 |
MP80-04 89ZR-DF-IAB2M AND 68GA-PSMA-11 IMAGING IN LOCALIZED PRE-PROSTATECTOMY PROSTATE CANCER PATIENTS MJ Niaz, Y Jhanwar, T Flynn, S Vallabhajosula, J Batra, S Tagawa, ... Journal of Urology 201, e1161-e1162, 2019 | 2 | 2019 |
Phase I dose-escalation study of fractionated-dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC). ST Tagawa, S Vallabhajosula, J Batra, PJ Christos, Y Jhanwar, ... Journal of Clinical Oncology 35 (15_suppl), TPS5093-TPS5093, 2017 | 2 | 2017 |
Anti-prostate-specific membrane antigen (PSMA) monoclonal antibody (mAb) J591 immunotherapy for prostate cancer ST Tagawa, D Scherr, J Batra, Y Jhanwar, B Robinson, D Nanus, ... Annals of Oncology 27, vi265, 2016 | 2 | 2016 |
89Zr-df-IAB2M for PET/CT imaging of prostate cancer JS Batra, YS Jhanwar, S Vallabhajosula, MJ Niaz, T Flynn, ST Tagawa, ... Eur J Nucl Med Mol Imaging 44 (Suppl 2), S119–S956, 2017 | 1* | 2017 |